Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20210323004Not yet recruiting
Open-label, single-arm trial in Tuberculosis (TB), sponsored by Chulalongkorn University. Primary endpoint: Pharmacokinetic parameters of antituberculosis drugs. Planned start Apr 2021; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20210323004.